Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

PHASE4CompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

June 27, 2016

Primary Completion Date

December 5, 2018

Study Completion Date

December 5, 2018

Conditions
Psoriatic Arthritis
Interventions
DRUG

Secukinumab 300 mg

150 mg x 2 s.c. injection

DRUG

Secukinumab 150 mg

150 mg s.c. injection

OTHER

Placebo

Placebo

Trial Locations (58)

11201

Novartis Investigative Site, Brooklyn

11402

Novartis Investigative Site, Lake Success

12206

Novartis Investigative Site, Albany

12983

Novartis Investigative Site, Saranac Lake

13676

Novartis Investigative Site, Potsdam

14127

Novartis Investigative Site, Orchard Park

16635

Novartis Investigative Site, Duncansville

19104

Novartis Investigative Site, Philadelphia

21224

Novartis Investigative Site, Baltimore

27408

Novartis Investigative Site, Greensboro

28226

Novartis Investigative Site, Charlotte

28562

Novartis Investigative Site, New Bern

29460

Novartis Investigative Site, Charleston

29601

Novartis Investigative Site, Greenville

30096

Novartis Investigative Site, Duluth

32207

Novartis Investigative Site, Jacksonville

32514

Novartis Investigative Site, Pensacola

32713

Novartis Investigative Site, DeBary

33180

Novartis Investigative Site, Aventura

33324

Novartis Investigative Site, Plantation

33609

Novartis Investigative Site, Tampa

33613

Novartis Investigative Site, Tampa

33765

Novartis Investigative Site, Clearwater

34102

Novartis Investigative Site, North Naples

34239

Novartis Investigative Site, Sarasota

34684

Novartis Investigative Site, Palm Harbor

35205

Novartis Investigative Site, Birmingham

38305

Novartis Investigative Site, Jackson

43302

Novartis Investigative Site, Marion

43551

Novartis Investigative Site, Perrysburg

49008

Novartis Investigative Site, Kalamazoo

49015

Novartis Investigative Site, Battle Creek

55121

Novartis Investigative Site, Eagan

68516

Novartis Investigative Site, Lincoln

72205

Novartis Investigative Site, Little Rock

75150

Novartis Investigative Site, Mesquite

75231

Novartis Investigative Site, Dallas

75246

Novartis Investigative Site, Dallas

76014

Novartis Investigative Site, Arlington

77074

Novartis Investigative Site, Houston

77373

Novartis Investigative Site, Arlington

78229

Novartis Investigative Site, San Antonio

78731

Novartis Investigative Site, Austin

84132

Novartis Investigative Site, Salt Lake City

89106

Novartis Investigative Site, Las Vegas

91786

Novartis Investigative Site, Upland

91942

Novartis Investigative Site, La Mesa

92020

Novartis Investigative Site, El Cajon

92093

Novartis Investigative Site, La Jolla

92708

Novartis Investigative Site, Fountain Valley

98122

Novartis Investigative Site, Seattle

99204

Novartis Investigative Site, Spokane

02115

Novartis Investigative Site, Boston

01655

Novartis Investigative Site, Worcester

07450

Novartis Investigative Site, Ridgewood

07901

Novartis Investigative Site, Summit

29118-2475

Novartis Investigative Site, Orangeburg

00909

Novartis Investigative Site, Santurce

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY